Bradley Merritt Wertheim, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypertension, Pulmonary | 9 | 2023 | 1534 | 1.760 |
Why?
|
Laryngeal Diseases | 1 | 2020 | 241 | 0.610 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2022 | 581 | 0.570 |
Why?
|
Airway Obstruction | 1 | 2020 | 664 | 0.530 |
Why?
|
Cardiomyopathy, Hypertrophic | 2 | 2022 | 1265 | 0.520 |
Why?
|
Microvessels | 1 | 2019 | 544 | 0.490 |
Why?
|
Inservice Training | 1 | 2016 | 392 | 0.460 |
Why?
|
Otolaryngology | 1 | 2020 | 645 | 0.460 |
Why?
|
Unnecessary Procedures | 2 | 2017 | 432 | 0.460 |
Why?
|
Cell Separation | 1 | 2019 | 1751 | 0.440 |
Why?
|
Endothelial Cells | 4 | 2023 | 3486 | 0.400 |
Why?
|
Clinical Laboratory Techniques | 1 | 2016 | 738 | 0.380 |
Why?
|
Biocompatible Materials | 1 | 2019 | 1736 | 0.370 |
Why?
|
Pulmonary Artery | 5 | 2023 | 1912 | 0.300 |
Why?
|
Ventricular Function, Right | 2 | 2022 | 591 | 0.290 |
Why?
|
Vascular Resistance | 2 | 2020 | 936 | 0.290 |
Why?
|
Academic Medical Centers | 2 | 2017 | 2760 | 0.290 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2021 | 2917 | 0.250 |
Why?
|
Lung | 2 | 2019 | 9857 | 0.230 |
Why?
|
Exercise Tolerance | 2 | 2018 | 768 | 0.220 |
Why?
|
Prostaglandins I | 1 | 2022 | 13 | 0.220 |
Why?
|
Biomass | 1 | 2023 | 125 | 0.210 |
Why?
|
Medical Order Entry Systems | 2 | 2017 | 545 | 0.200 |
Why?
|
Bufanolides | 1 | 2020 | 5 | 0.190 |
Why?
|
Amaryllidaceae Alkaloids | 1 | 2020 | 3 | 0.180 |
Why?
|
Phenanthridines | 1 | 2020 | 51 | 0.180 |
Why?
|
Exercise Test | 3 | 2024 | 2073 | 0.170 |
Why?
|
Pulmonary Wedge Pressure | 1 | 2019 | 264 | 0.160 |
Why?
|
Pulmonary Circulation | 1 | 2021 | 739 | 0.160 |
Why?
|
Collagen Type III | 1 | 2018 | 90 | 0.160 |
Why?
|
Pharynx | 1 | 2020 | 413 | 0.160 |
Why?
|
Antigens, Differentiation | 1 | 2019 | 927 | 0.130 |
Why?
|
Cardiac Output | 1 | 2017 | 854 | 0.130 |
Why?
|
Fibrosis | 2 | 2020 | 2029 | 0.130 |
Why?
|
Cell Adhesion | 1 | 2021 | 3144 | 0.120 |
Why?
|
Early Diagnosis | 1 | 2019 | 1184 | 0.120 |
Why?
|
Organizational Policy | 1 | 2016 | 429 | 0.120 |
Why?
|
Cardiovascular Agents | 1 | 2020 | 850 | 0.110 |
Why?
|
Dyspnea | 1 | 2020 | 1303 | 0.110 |
Why?
|
Diagnostic Tests, Routine | 1 | 2017 | 783 | 0.100 |
Why?
|
Deoxyribodipyrimidine Photo-Lyase | 1 | 2010 | 3 | 0.100 |
Why?
|
Flavobacterium | 1 | 2010 | 20 | 0.090 |
Why?
|
Cryptochromes | 1 | 2010 | 45 | 0.090 |
Why?
|
Electrocardiography | 1 | 2024 | 6442 | 0.090 |
Why?
|
Soil Microbiology | 1 | 2010 | 87 | 0.090 |
Why?
|
Heart Ventricles | 1 | 2022 | 3817 | 0.090 |
Why?
|
Silicon Dioxide | 1 | 2010 | 213 | 0.080 |
Why?
|
Phosphoproteins | 1 | 2018 | 2441 | 0.080 |
Why?
|
Heart Failure | 2 | 2024 | 10895 | 0.080 |
Why?
|
Fibroblasts | 1 | 2020 | 4162 | 0.080 |
Why?
|
Humans | 19 | 2024 | 744366 | 0.080 |
Why?
|
Pulmonary Embolism | 1 | 2021 | 2375 | 0.080 |
Why?
|
Decision Support Systems, Clinical | 1 | 2017 | 1164 | 0.080 |
Why?
|
Cardiomyopathies | 1 | 2020 | 1912 | 0.080 |
Why?
|
Mitochondria | 1 | 2020 | 3514 | 0.070 |
Why?
|
Biofilms | 1 | 2010 | 617 | 0.070 |
Why?
|
Rats | 2 | 2019 | 24252 | 0.070 |
Why?
|
Middle Aged | 8 | 2024 | 213390 | 0.060 |
Why?
|
Vibrio cholerae | 1 | 2010 | 807 | 0.060 |
Why?
|
Boston | 1 | 2016 | 9312 | 0.060 |
Why?
|
Male | 11 | 2024 | 350115 | 0.050 |
Why?
|
Signal Transduction | 2 | 2021 | 23404 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2019 | 12073 | 0.050 |
Why?
|
Rats, Inbred Dahl | 1 | 2020 | 35 | 0.050 |
Why?
|
Selenoprotein P | 1 | 2020 | 32 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 2 | 2020 | 6539 | 0.040 |
Why?
|
Smad3 Protein | 1 | 2018 | 180 | 0.040 |
Why?
|
Escherichia coli | 1 | 2010 | 4217 | 0.040 |
Why?
|
Tennessee | 1 | 2017 | 117 | 0.040 |
Why?
|
Thermodilution | 1 | 2017 | 52 | 0.040 |
Why?
|
Diastole | 1 | 2020 | 791 | 0.040 |
Why?
|
Oxygen Consumption | 1 | 2024 | 1868 | 0.040 |
Why?
|
Laboratories, Hospital | 1 | 2017 | 194 | 0.030 |
Why?
|
Animals | 4 | 2021 | 168768 | 0.030 |
Why?
|
Female | 8 | 2024 | 380193 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2021 | 19233 | 0.030 |
Why?
|
Systems Biology | 1 | 2018 | 469 | 0.030 |
Why?
|
Models, Animal | 1 | 2021 | 2173 | 0.030 |
Why?
|
High-Throughput Screening Assays | 1 | 2020 | 944 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 3873 | 0.030 |
Why?
|
Protein Binding | 2 | 2018 | 9384 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2018 | 15160 | 0.030 |
Why?
|
Extracellular Matrix | 1 | 2020 | 1741 | 0.030 |
Why?
|
Prognosis | 2 | 2024 | 29060 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2022 | 77460 | 0.020 |
Why?
|
Flavin-Adenine Dinucleotide | 1 | 2010 | 29 | 0.020 |
Why?
|
Calorimetry | 1 | 2010 | 126 | 0.020 |
Why?
|
Blood Platelets | 1 | 2021 | 2509 | 0.020 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 2010 | 220 | 0.020 |
Why?
|
Organic Chemicals | 1 | 2010 | 211 | 0.020 |
Why?
|
Thermodynamics | 1 | 2010 | 594 | 0.020 |
Why?
|
Hypertension | 2 | 2020 | 8479 | 0.020 |
Why?
|
Spectrum Analysis, Raman | 1 | 2010 | 247 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10252 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2020 | 3666 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2018 | 8300 | 0.020 |
Why?
|
Myocardium | 1 | 2020 | 4772 | 0.020 |
Why?
|
Aged | 4 | 2020 | 163288 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2010 | 1101 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2010 | 2184 | 0.020 |
Why?
|
Heart Diseases | 1 | 2017 | 2789 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2020 | 10483 | 0.010 |
Why?
|
MicroRNAs | 1 | 2020 | 3751 | 0.010 |
Why?
|
Apoptosis | 1 | 2020 | 9724 | 0.010 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2017 | 2200 | 0.010 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 3047 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2010 | 1917 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2020 | 21833 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18034 | 0.010 |
Why?
|
Adult | 2 | 2024 | 214052 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2017 | 5749 | 0.010 |
Why?
|
Hospitalization | 1 | 2018 | 10259 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2017 | 39052 | 0.010 |
Why?
|
Mice | 1 | 2021 | 81201 | 0.010 |
Why?
|
Risk Factors | 1 | 2020 | 72296 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2017 | 63107 | 0.010 |
Why?
|